Suven Life Sciences Limited | SUVEN | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Revenue |
| 5,645 | 6,253 | 6,635 | 285 | 212 |
Cost of revenue |
| -2,334 | -2,419 | -2,733 | -1,032 | -710 |
Gross Profit |
| 3,311 | 3,833 | 3,902 | -748 | -498 |
Sales, general & ad... |
| -1,820 | -1,851 | -2,297 | -270 | -225 |
Depreciation |
| -214 | -213 | -221 | -42 | -43 |
Provision |
| 0 | 0 | 0 | 0 | 0 |
Other op inc/exp... |
| 0 | 0 | 0 | 0 | 0 |
Operating income |
| 1,277 | 1,769 | 1,383 | -1,059 | -767 |
Profit before tax |
| 1,231 | 1,955 | 1,587 | -1,064 | -775 |
Net Income |
| 872 | 1,237 | 869 | -942 | -722 |
| | | | | ||
EPS Basic |
| 6.85 | 9.72 | 6.83 | -7.40 | -5.67 |